speb/financial-data huggingface dataset:
UROY income_statement (annual, 2024-04-30) — Other Non Operating Income Expenses: 198000.00
UROY income_statement (annual, 2024-04-30) — Other Operating Expenses: 757000.00
UROY balance_sheet (annual, 2024-04-30) — Other Payable: 1519000.00
UROY balance_sheet (annual, 2024-04-30) — Other Properties: 181000.00
UROY balance_sheet (annual, 2024-04-30) — Other Receivables: 490000.00
UROY balance_sheet (annual, 2024-04-30) — Other Short Term Investments: 9143000.00
UROY balance_sheet (annual, 2024-04-30) — Payables: 2721000.00
UROY balance_sheet (annual, 2024-04-30) — Payables And Accrued Expenses: 2721000.00
UROY income_statement (annual, 2024-04-30) — Pretax Income: 7757000.00
UROY cash_flow (annual, 2024-04-30) — Proceeds From Stock Option Exercised: 5900000.00
UROY cash_flow (annual, 2024-04-30) — Purchase Of Investment: -769000.00
UROY cash_flow (annual, 2024-04-30) — Purchase Of PPE: -75000.00
UROY balance_sheet (annual, 2024-04-30) — Receivables: 14308000.00
UROY income_statement (annual, 2024-04-30) — Reconciled Cost Of Revenue: 27951000.00
UROY income_statement (annual, 2024-04-30) — Reconciled Depreciation: 23000.00
UROY cash_flow (annual, 2024-04-30) — Repayment Of Debt: -9609000.00
UROY balance_sheet (annual, 2024-04-30) — Restricted Cash: 110000.00
UROY balance_sheet (annual, 2024-04-30) — Retained Earnings: 22522000.00
UROY income_statement (annual, 2024-04-30) — Salaries And Wages: 1804000.00
UROY cash_flow (annual, 2024-04-30) — Sale Of Investment: 45386000.00
UROY income_statement (annual, 2024-04-30) — Selling General And Administration: 6921000.00
UROY balance_sheet (annual, 2024-04-30) — Share Issued: 120554333.00
UROY cash_flow (annual, 2024-04-30) — Short Term Debt Payments: -9589000.00
UROY cash_flow (annual, 2024-04-30) — Stock Based Compensation: 738000.00
UROY balance_sheet (annual, 2024-04-30) — Stockholders Equity: 275789000.00
UROY balance_sheet (annual, 2024-04-30) — Tangible Book Value: 275789000.00
UROY income_statement (annual, 2024-04-30) — Tax Effect Of Unusual Items: -30150.00
UROY income_statement (annual, 2024-04-30) — Tax Provision: -2023000.00
UROY income_statement (annual, 2024-04-30) — Tax Rate For Calcs: 0.15
UROY balance_sheet (annual, 2024-04-30) — Total Assets: 278703000.00
UROY balance_sheet (annual, 2024-04-30) — Total Capitalization: 275789000.00
UROY balance_sheet (annual, 2024-04-30) — Total Debt: 193000.00
UROY balance_sheet (annual, 2024-04-30) — Total Equity Gross Minority Interest: 275789000.00
UROY income_statement (annual, 2024-04-30) — Total Expenses: 35629000.00
UROY balance_sheet (annual, 2024-04-30) — Total Liabilities Net Minority Interest: 2914000.00
UROY balance_sheet (annual, 2024-04-30) — Total Non Current Assets: 46952000.00
UROY balance_sheet (annual, 2024-04-30) — Total Non Current Liabilities Net Minority Interest: 156000.00
UROY income_statement (annual, 2024-04-30) — Total Operating Income As Reported: 7077000.00
UROY income_statement (annual, 2024-04-30) — Total Unusual Items: -201000.00
UROY income_statement (annual, 2024-04-30) — Total Unusual Items Excluding Goodwill: -201000.00
UROY balance_sheet (annual, 2024-04-30) — Working Capital: 228993000.00
UROY income_statement (quarterly, 2024-10-31) — Basic Average Shares: 121970820.00
UROY income_statement (quarterly, 2024-10-31) — Basic EPS: 0.00
UROY cash_flow (quarterly, 2024-10-31) — Capital Expenditure: -6201000.00
UROY cash_flow (quarterly, 2024-10-31) — Cash Dividends Paid: 0.00
UROY cash_flow (quarterly, 2024-10-31) — Change In Payable: 158000.00
UROY balance_sheet (quarterly, 2024-10-31) — Current Debt: 18933000.00
UROY income_statement (quarterly, 2024-10-31) — Diluted Average Shares: 121970820.00
UROY income_statement (quarterly, 2024-10-31) — Diluted EPS: 0.00
UROY cash_flow (quarterly, 2024-10-31) — Interest Paid Cff: 0.00
UROY balance_sheet (quarterly, 2024-10-31) — Net Debt: 6002000.00
UROY balance_sheet (quarterly, 2024-10-31) — Other Current Borrowings: 18933000.00
UROY balance_sheet (quarterly, 2024-10-31) — Other Equity Interest: 240000.00
UROY income_statement (quarterly, 2024-10-31) — Total Other Finance Cost: 312000.00
UROY income_statement (quarterly, 2025-01-31) — +Operating Expense: 1748000.00
UROY income_statement (quarterly, 2025-01-31) — +Total Revenue: 4000.00
UROY balance_sheet (quarterly, 2025-01-31) — Accounts Payable: 1053000.00
UROY balance_sheet (quarterly, 2025-01-31) — Accounts Receivable: 0.00
UROY balance_sheet (quarterly, 2025-01-31) — Accumulated Depreciation: -1069000.00
UROY income_statement (quarterly, 2025-01-31) — Basic Average Shares: 130991063.00
UROY income_statement (quarterly, 2025-01-31) — Basic EPS: -0.01
UROY cash_flow (quarterly, 2025-01-31) — Beginning Cash Position: 12931000.00
UROY balance_sheet (quarterly, 2025-01-31) — Capital Lease Obligations: 222000.00
UROY balance_sheet (quarterly, 2025-01-31) — Capital Stock: 273754000.00
UROY balance_sheet (quarterly, 2025-01-31) — Cash And Cash Equivalents: 9657000.00
UROY balance_sheet (quarterly, 2025-01-31) — Cash Cash Equivalents And Short Term Investments: 17298000.00
UROY cash_flow (quarterly, 2025-01-31) — Cash Dividends Paid: 0.00
UROY balance_sheet (quarterly, 2025-01-31) — Cash Financial: 9657000.00
UROY cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Financing Activities: -1694000.00
UROY cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Investing Activities: 132000.00
UROY cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Operating Activities: -2131000.00
UROY cash_flow (quarterly, 2025-01-31) — Change In Account Payable: -280000.00
UROY cash_flow (quarterly, 2025-01-31) — Change In Inventory: 0.00
UROY cash_flow (quarterly, 2025-01-31) — Change In Payable: -280000.00
UROY cash_flow (quarterly, 2025-01-31) — Change In Payables And Accrued Expense: -280000.00
UROY cash_flow (quarterly, 2025-01-31) — Change In Prepaid Assets: -378000.00
UROY cash_flow (quarterly, 2025-01-31) — Change In Receivables: 41000.00
UROY cash_flow (quarterly, 2025-01-31) — Change In Working Capital: -617000.00
UROY cash_flow (quarterly, 2025-01-31) — Changes In Account Receivables: 41000.00
UROY cash_flow (quarterly, 2025-01-31) — Changes In Cash: -3693000.00
UROY balance_sheet (quarterly, 2025-01-31) — Common Stock: 273754000.00
UROY balance_sheet (quarterly, 2025-01-31) — Common Stock Equity: 297384000.00
UROY cash_flow (quarterly, 2025-01-31) — Common Stock Issuance: -240000.00
UROY income_statement (quarterly, 2025-01-31) — Cost Of Revenue: 4000.00
UROY balance_sheet (quarterly, 2025-01-31) — Current Assets: 239320000.00
UROY balance_sheet (quarterly, 2025-01-31) — Current Capital Lease Obligation: 52000.00
UROY balance_sheet (quarterly, 2025-01-31) — Current Debt And Capital Lease Obligation: 52000.00
UROY balance_sheet (quarterly, 2025-01-31) — Current Liabilities: 1105000.00
UROY cash_flow (quarterly, 2025-01-31) — Depletion: 4000.00
UROY cash_flow (quarterly, 2025-01-31) — Depreciation: 13000.00
UROY cash_flow (quarterly, 2025-01-31) — Depreciation Amortization Depletion: 17000.00
UROY cash_flow (quarterly, 2025-01-31) — Depreciation And Amortization: 13000.00
UROY income_statement (quarterly, 2025-01-31) — Diluted Average Shares: 130991063.00
UROY income_statement (quarterly, 2025-01-31) — Diluted EPS: -0.01
UROY income_statement (quarterly, 2025-01-31) — Diluted NI Availto Com Stockholders: -1911000.00
UROY income_statement (quarterly, 2025-01-31) — EBIT: -1780000.00
UROY income_statement (quarterly, 2025-01-31) — EBITDA: -1763000.00
UROY cash_flow (quarterly, 2025-01-31) — Effect Of Exchange Rate Changes: 419000.00
UROY cash_flow (quarterly, 2025-01-31) — End Cash Position: 9657000.00
UROY cash_flow (quarterly, 2025-01-31) — Financing Cash Flow: -1694000.00
UROY cash_flow (quarterly, 2025-01-31) — Free Cash Flow: -2131000.00
UROY income_statement (quarterly, 2025-01-31) — Gain On Sale Of Security: -281000.00
UROY balance_sheet (quarterly, 2025-01-31) — Gains Losses Not Affecting Retained Earnings: 5247000.00
UROY income_statement (quarterly, 2025-01-31) — General And Administrative Expense: 1673000.00
UROY balance_sheet (quarterly, 2025-01-31) — Gross PPE: 60408000.00
UROY income_statement (quarterly, 2025-01-31) — Gross Profit: 0.00
UROY income_statement (quarterly, 2025-01-31) — Interest Expense: 5000.00
UROY income_statement (quarterly, 2025-01-31) — Interest Expense Non Operating: 5000.00
UROY income_statement (quarterly, 2025-01-31) — Interest Income: 131000.00
UROY income_statement (quarterly, 2025-01-31) — Interest Income Non Operating: 131000.00
UROY cash_flow (quarterly, 2025-01-31) — Interest Paid Cff: -439000.00
UROY cash_flow (quarterly, 2025-01-31) — Interest Received Cfi: 132000.00
UROY balance_sheet (quarterly, 2025-01-31) — Inventory: 221316000.00
UROY balance_sheet (quarterly, 2025-01-31) — Invested Capital: 297384000.00
UROY cash_flow (quarterly, 2025-01-31) — Investing Cash Flow: 132000.00
UROY cash_flow (quarterly, 2025-01-31) — Issuance Of Capital Stock: -240000.00
UROY balance_sheet (quarterly, 2025-01-31) — Long Term Capital Lease Obligation: 170000.00
UROY balance_sheet (quarterly, 2025-01-31) — Long Term Debt And Capital Lease Obligation: 170000.00
UROY cash_flow (quarterly, 2025-01-31) — Long Term Debt Payments: -17000.00
UROY cash_flow (quarterly, 2025-01-31) — Net Common Stock Issuance: -240000.00
UROY cash_flow (quarterly, 2025-01-31) — Net Foreign Currency Exchange Gain Loss: 281000.00
UROY income_statement (quarterly, 2025-01-31) — Net Income: -1911000.00
UROY income_statement (quarterly, 2025-01-31) — Net Income Common Stockholders: -1911000.00
UROY income_statement (quarterly, 2025-01-31) — Net Income Continuous Operations: -1911000.00
UROY income_statement (quarterly, 2025-01-31) — Net Income From Continuing And Discontinued Operation: -1911000.00
UROY income_statement (quarterly, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: -1911000.00
UROY cash_flow (quarterly, 2025-01-31) — Net Income From Continuing Operations: -1785000.00
UROY income_statement (quarterly, 2025-01-31) — Net Income Including Noncontrolling Interests: -1911000.00
UROY income_statement (quarterly, 2025-01-31) — Net Interest Income: 20000.00
UROY cash_flow (quarterly, 2025-01-31) — Net Investment Purchase And Sale: 0.00
UROY cash_flow (quarterly, 2025-01-31) — Net Issuance Payments Of Debt: -19318000.00
UROY cash_flow (quarterly, 2025-01-31) — Net Long Term Debt Issuance: -17000.00
UROY income_statement (quarterly, 2025-01-31) — Net Non Operating Interest Income Expense: 20000.00
UROY cash_flow (quarterly, 2025-01-31) — Net Other Financing Charges: 0.00
UROY balance_sheet (quarterly, 2025-01-31) — Net PPE: 59339000.00
UROY cash_flow (quarterly, 2025-01-31) — Net PPE Purchase And Sale: 0.00
UROY balance_sheet (quarterly, 2025-01-31) — Net Tangible Assets: 297384000.00
UROY income_statement (quarterly, 2025-01-31) — Normalized EBITDA: -1482000.00
UROY income_statement (quarterly, 2025-01-31) — Normalized Income: -1672150.00
UROY cash_flow (quarterly, 2025-01-31) — Operating Cash Flow: -2131000.00
UROY cash_flow (quarterly, 2025-01-31) — Operating Gains Losses: 281000.00
UROY income_statement (quarterly, 2025-01-31) — Operating Income: -1748000.00
UROY income_statement (quarterly, 2025-01-31) — Operating Revenue: 4000.00
UROY balance_sheet (quarterly, 2025-01-31) — Ordinary Shares Number: 133592119.00
UROY balance_sheet (quarterly, 2025-01-31) — Other Equity Adjustments: 5247000.00
UROY income_statement (quarterly, 2025-01-31) — Other Gand A: 1172000.00
UROY income_statement (quarterly, 2025-01-31) — Other Income Expense: -57000.00
UROY cash_flow (quarterly, 2025-01-31) — Other Non Cash Items: -244000.00
UROY income_statement (quarterly, 2025-01-31) — Other Non Operating Income Expenses: 224000.00
UROY income_statement (quarterly, 2025-01-31) — Other Operating Expenses: 75000.00
UROY balance_sheet (quarterly, 2025-01-31) — Other Properties: 203000.00
UROY balance_sheet (quarterly, 2025-01-31) — Other Receivables: 596000.00
UROY balance_sheet (quarterly, 2025-01-31) — Other Short Term Investments: 7641000.00
UROY balance_sheet (quarterly, 2025-01-31) — Payables: 1053000.00
UROY balance_sheet (quarterly, 2025-01-31) — Payables And Accrued Expenses: 1053000.00
UROY income_statement (quarterly, 2025-01-31) — Pretax Income: -1785000.00
UROY cash_flow (quarterly, 2025-01-31) — Proceeds From Stock Option Exercised: 18303000.00
UROY cash_flow (quarterly, 2025-01-31) — Purchase Of Investment: 0.00
UROY cash_flow (quarterly, 2025-01-31) — Purchase Of PPE: 0.00
UROY balance_sheet (quarterly, 2025-01-31) — Receivables: 596000.00
UROY income_statement (quarterly, 2025-01-31) — Reconciled Cost Of Revenue: 4000.00
UROY income_statement (quarterly, 2025-01-31) — Reconciled Depreciation: 17000.00
UROY cash_flow (quarterly, 2025-01-31) — Repayment Of Debt: -19318000.00
UROY balance_sheet (quarterly, 2025-01-31) — Restricted Cash: 110000.00
UROY balance_sheet (quarterly, 2025-01-31) — Retained Earnings: 18383000.00
UROY income_statement (quarterly, 2025-01-31) — Salaries And Wages: 501000.00
UROY cash_flow (quarterly, 2025-01-31) — Sale Of Investment: 0.00
UROY income_statement (quarterly, 2025-01-31) — Selling General And Administration: 1673000.00
UROY balance_sheet (quarterly, 2025-01-31) — Share Issued: 133592119.00
UROY cash_flow (quarterly, 2025-01-31) — Stock Based Compensation: 217000.00
UROY balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: 297384000.00
UROY balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: 297384000.00
UROY income_statement (quarterly, 2025-01-31) — Tax Effect Of Unusual Items: -42150.00
UROY income_statement (quarterly, 2025-01-31) — Tax Provision: 126000.00
UROY income_statement (quarterly, 2025-01-31) — Tax Rate For Calcs: 0.15
UROY balance_sheet (quarterly, 2025-01-31) — Total Assets: 298659000.00
UROY balance_sheet (quarterly, 2025-01-31) — Total Capitalization: 297384000.00
UROY balance_sheet (quarterly, 2025-01-31) — Total Debt: 222000.00
UROY balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: 297384000.00
UROY income_statement (quarterly, 2025-01-31) — Total Expenses: 1752000.00
UROY balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 1275000.00
UROY balance_sheet (quarterly, 2025-01-31) — Total Non Current Assets: 59339000.00
UROY balance_sheet (quarterly, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 170000.00
UROY income_statement (quarterly, 2025-01-31) — Total Operating Income As Reported: -1748000.00
UROY income_statement (quarterly, 2025-01-31) — Total Other Finance Cost: 106000.00
UROY income_statement (quarterly, 2025-01-31) — Total Unusual Items: -281000.00
UROY income_statement (quarterly, 2025-01-31) — Total Unusual Items Excluding Goodwill: -281000.00
UROY balance_sheet (quarterly, 2025-01-31) — Working Capital: 238215000.00
UROY income_statement (annual, 2025-04-30) — +Operating Expense: 8343000.00
UROY income_statement (quarterly, 2025-04-30) — +Operating Expense: 1642000.00
UROY income_statement (annual, 2025-04-30) — +Total Revenue: 15595000.00
UROY income_statement (quarterly, 2025-04-30) — +Total Revenue: 4688000.00
UROY balance_sheet (annual, 2025-04-30) — Accounts Payable: 968000.00
UROY balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 968000.00
UROY balance_sheet (annual, 2025-04-30) — Accounts Receivable: 42000.00
UROY balance_sheet (quarterly, 2025-04-30) — Accounts Receivable: 42000.00
UROY balance_sheet (annual, 2025-04-30) — Accumulated Depreciation: -1267000.00
UROY balance_sheet (quarterly, 2025-04-30) — Accumulated Depreciation: -1267000.00
UROY income_statement (annual, 2025-04-30) — Basic Average Shares: 126795491.00
UROY income_statement (annual, 2025-04-30) — Basic EPS: -0.04
UROY cash_flow (annual, 2025-04-30) — Beginning Cash Position: 21100000.00
UROY cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 9657000.00
UROY cash_flow (annual, 2025-04-30) — Capital Expenditure: -11584000.00
UROY balance_sheet (annual, 2025-04-30) — Capital Lease Obligations: 209000.00
UROY balance_sheet (quarterly, 2025-04-30) — Capital Lease Obligations: 209000.00
UROY balance_sheet (annual, 2025-04-30) — Capital Stock: 273952000.00
UROY balance_sheet (quarterly, 2025-04-30) — Capital Stock: 273952000.00
UROY balance_sheet (annual, 2025-04-30) — Cash And Cash Equivalents: 12935000.00
UROY balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 12935000.00
UROY balance_sheet (annual, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 20082000.00
UROY balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 20082000.00
UROY cash_flow (annual, 2025-04-30) — Cash Dividends Paid: 0.00
UROY cash_flow (quarterly, 2025-04-30) — Cash Dividends Paid: 0.00
UROY balance_sheet (annual, 2025-04-30) — Cash Financial: 12935000.00
UROY balance_sheet (quarterly, 2025-04-30) — Cash Financial: 12935000.00
UROY cash_flow (annual, 2025-04-30) — Cash Flow From Continuing Financing Activities: 24386000.00
UROY cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: 109000.00
UROY cash_flow (annual, 2025-04-30) — Cash Flow From Continuing Investing Activities: -11359000.00
UROY cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Investing Activities: 76000.00
UROY cash_flow (annual, 2025-04-30) — Cash Flow From Continuing Operating Activities: -21630000.00
UROY cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: 3275000.00
UROY cash_flow (annual, 2025-04-30) — Change In Account Payable: -234000.00
UROY cash_flow (quarterly, 2025-04-30) — Change In Account Payable: -85000.00
UROY cash_flow (annual, 2025-04-30) — Change In Inventory: -29815000.00
UROY cash_flow (quarterly, 2025-04-30) — Change In Inventory: 3981000.00
UROY cash_flow (annual, 2025-04-30) — Change In Payable: -1753000.00
UROY cash_flow (quarterly, 2025-04-30) — Change In Payable: -85000.00
UROY cash_flow (annual, 2025-04-30) — Change In Payables And Accrued Expense: -1753000.00
UROY cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: -85000.00
UROY cash_flow (annual, 2025-04-30) — Change In Prepaid Assets: 64000.00
UROY cash_flow (quarterly, 2025-04-30) — Change In Prepaid Assets: 170000.00
UROY cash_flow (annual, 2025-04-30) — Change In Receivables: 13776000.00
UROY cash_flow (quarterly, 2025-04-30) — Change In Receivables: -42000.00
UROY cash_flow (annual, 2025-04-30) — Change In Working Capital: -17728000.00
UROY cash_flow (quarterly, 2025-04-30) — Change In Working Capital: 4024000.00
UROY cash_flow (annual, 2025-04-30) — Changes In Account Receivables: 13776000.00
UROY cash_flow (quarterly, 2025-04-30) — Changes In Account Receivables: -42000.00
UROY cash_flow (annual, 2025-04-30) — Changes In Cash: -8603000.00
UROY cash_flow (quarterly, 2025-04-30) — Changes In Cash: 3460000.00
UROY balance_sheet (annual, 2025-04-30) — Common Stock: 273952000.00
UROY balance_sheet (quarterly, 2025-04-30) — Common Stock: 273952000.00
UROY balance_sheet (annual, 2025-04-30) — Common Stock Equity: 294892000.00
UROY balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 294892000.00
UROY cash_flow (annual, 2025-04-30) — Common Stock Issuance: 0.00
UROY cash_flow (quarterly, 2025-04-30) — Common Stock Issuance: 0.00
UROY income_statement (annual, 2025-04-30) — Cost Of Revenue: 12058000.00
UROY income_statement (quarterly, 2025-04-30) — Cost Of Revenue: 4026000.00
UROY balance_sheet (annual, 2025-04-30) — Current Assets: 238161000.00
UROY balance_sheet (quarterly, 2025-04-30) — Current Assets: 238161000.00
UROY balance_sheet (annual, 2025-04-30) — Current Capital Lease Obligation: 52000.00
UROY balance_sheet (quarterly, 2025-04-30) — Current Capital Lease Obligation: 52000.00
UROY balance_sheet (annual, 2025-04-30) — Current Debt And Capital Lease Obligation: 52000.00
UROY balance_sheet (quarterly, 2025-04-30) — Current Debt And Capital Lease Obligation: 52000.00
UROY balance_sheet (annual, 2025-04-30) — Current Liabilities: 1020000.00
UROY balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 1020000.00
UROY cash_flow (annual, 2025-04-30) — Depletion: 65000.00
UROY cash_flow (quarterly, 2025-04-30) — Depletion: 31000.00
UROY cash_flow (annual, 2025-04-30) — Depreciation: 55000.00
UROY cash_flow (quarterly, 2025-04-30) — Depreciation: 14000.00
UROY cash_flow (annual, 2025-04-30) — Depreciation Amortization Depletion: 120000.00
UROY cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 45000.00
UROY cash_flow (annual, 2025-04-30) — Depreciation And Amortization: 55000.00
UROY cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 14000.00
UROY income_statement (annual, 2025-04-30) — Diluted Average Shares: 126795491.00
UROY income_statement (annual, 2025-04-30) — Diluted EPS: -0.04
UROY income_statement (annual, 2025-04-30) — Diluted NI Availto Com Stockholders: -5654000.00
UROY income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: -1157000.00
UROY income_statement (annual, 2025-04-30) — EBIT: -5290000.00
UROY income_statement (quarterly, 2025-04-30) — EBIT: -1087000.00
UROY income_statement (annual, 2025-04-30) — EBITDA: -5170000.00
UROY income_statement (quarterly, 2025-04-30) — EBITDA: -1042000.00
UROY cash_flow (annual, 2025-04-30) — Effect Of Exchange Rate Changes: 438000.00
UROY cash_flow (quarterly, 2025-04-30) — Effect Of Exchange Rate Changes: -182000.00
UROY cash_flow (annual, 2025-04-30) — End Cash Position: 12935000.00
UROY cash_flow (quarterly, 2025-04-30) — End Cash Position: 12935000.00
UROY cash_flow (annual, 2025-04-30) — Financing Cash Flow: 24386000.00
UROY cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: 109000.00
UROY cash_flow (annual, 2025-04-30) — Free Cash Flow: -33214000.00
UROY cash_flow (quarterly, 2025-04-30) — Free Cash Flow: 3275000.00
UROY income_statement (annual, 2025-04-30) — Gain On Sale Of Security: -865000.00
UROY income_statement (quarterly, 2025-04-30) — Gain On Sale Of Security: -183000.00
UROY balance_sheet (annual, 2025-04-30) — Gains Losses Not Affecting Retained Earnings: 3714000.00
UROY balance_sheet (quarterly, 2025-04-30) — Gains Losses Not Affecting Retained Earnings: 3714000.00
UROY income_statement (annual, 2025-04-30) — General And Administrative Expense: 7845000.00
UROY income_statement (quarterly, 2025-04-30) — General And Administrative Expense: 1568000.00
UROY balance_sheet (annual, 2025-04-30) — Gross PPE: 59175000.00
UROY balance_sheet (quarterly, 2025-04-30) — Gross PPE: 59175000.00
UROY income_statement (annual, 2025-04-30) — Gross Profit: 3537000.00
UROY income_statement (quarterly, 2025-04-30) — Gross Profit: 662000.00
UROY income_statement (annual, 2025-04-30) — Interest Expense: 18000.00
UROY income_statement (quarterly, 2025-04-30) — Interest Expense: 4000.00
UROY income_statement (annual, 2025-04-30) — Interest Expense Non Operating: 18000.00
UROY income_statement (quarterly, 2025-04-30) — Interest Expense Non Operating: 4000.00
UROY income_statement (annual, 2025-04-30) — Interest Income: 575000.00
UROY income_statement (quarterly, 2025-04-30) — Interest Income: 76000.00
UROY income_statement (annual, 2025-04-30) — Interest Income Non Operating: 575000.00
UROY income_statement (quarterly, 2025-04-30) — Interest Income Non Operating: 76000.00
UROY cash_flow (annual, 2025-04-30) — Interest Paid Cff: -439000.00
UROY cash_flow (quarterly, 2025-04-30) — Interest Paid Cff: 0.00
UROY cash_flow (annual, 2025-04-30) — Interest Received Cfi: 575000.00
UROY cash_flow (quarterly, 2025-04-30) — Interest Received Cfi: 76000.00
UROY balance_sheet (annual, 2025-04-30) — Inventory: 217501000.00
UROY balance_sheet (quarterly, 2025-04-30) — Inventory: 217501000.00
UROY balance_sheet (annual, 2025-04-30) — Invested Capital: 294892000.00
UROY balance_sheet (quarterly, 2025-04-30) — Invested Capital: 294892000.00
UROY cash_flow (annual, 2025-04-30) — Investing Cash Flow: -11359000.00
UROY cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: 76000.00
UROY cash_flow (annual, 2025-04-30) — Issuance Of Capital Stock: 0.00
UROY cash_flow (quarterly, 2025-04-30) — Issuance Of Capital Stock: 0.00
UROY balance_sheet (annual, 2025-04-30) — Long Term Capital Lease Obligation: 157000.00
UROY balance_sheet (quarterly, 2025-04-30) — Long Term Capital Lease Obligation: 157000.00
UROY balance_sheet (annual, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 157000.00
UROY balance_sheet (quarterly, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 157000.00
UROY cash_flow (annual, 2025-04-30) — Long Term Debt Payments: -65000.00
UROY cash_flow (quarterly, 2025-04-30) — Long Term Debt Payments: -17000.00
UROY cash_flow (annual, 2025-04-30) — Net Common Stock Issuance: 0.00
UROY cash_flow (quarterly, 2025-04-30) — Net Common Stock Issuance: 0.00
UROY cash_flow (annual, 2025-04-30) — Net Foreign Currency Exchange Gain Loss: 865000.00
UROY cash_flow (quarterly, 2025-04-30) — Net Foreign Currency Exchange Gain Loss: 183000.00
UROY income_statement (annual, 2025-04-30) — Net Income: -5654000.00
UROY income_statement (quarterly, 2025-04-30) — Net Income: -1157000.00
UROY income_statement (annual, 2025-04-30) — Net Income Common Stockholders: -5654000.00
UROY income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: -1157000.00
UROY income_statement (annual, 2025-04-30) — Net Income Continuous Operations: -5654000.00
UROY income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: -1157000.00
UROY income_statement (annual, 2025-04-30) — Net Income From Continuing And Discontinued Operation: -5654000.00
UROY income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: -1157000.00
UROY income_statement (annual, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: -5654000.00
UROY income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: -1157000.00
UROY cash_flow (annual, 2025-04-30) — Net Income From Continuing Operations: -5308000.00
UROY cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: -1091000.00
UROY income_statement (annual, 2025-04-30) — Net Income Including Noncontrolling Interests: -5654000.00
UROY income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: -1157000.00
UROY income_statement (annual, 2025-04-30) — Net Interest Income: 139000.00
UROY income_statement (quarterly, 2025-04-30) — Net Interest Income: 72000.00
UROY cash_flow (annual, 2025-04-30) — Net Investment Purchase And Sale: -350000.00
UROY cash_flow (quarterly, 2025-04-30) — Net Investment Purchase And Sale: 0.00
UROY cash_flow (annual, 2025-04-30) — Net Issuance Payments Of Debt: -65000.00
UROY cash_flow (quarterly, 2025-04-30) — Net Issuance Payments Of Debt: 1265000.00
UROY cash_flow (annual, 2025-04-30) — Net Long Term Debt Issuance: -65000.00
UROY cash_flow (quarterly, 2025-04-30) — Net Long Term Debt Issuance: -17000.00
UROY income_statement (annual, 2025-04-30) — Net Non Operating Interest Income Expense: 139000.00
UROY income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: 72000.00
UROY cash_flow (annual, 2025-04-30) — Net Other Financing Charges: -1282000.00
UROY balance_sheet (annual, 2025-04-30) — Net PPE: 57908000.00
UROY balance_sheet (quarterly, 2025-04-30) — Net PPE: 57908000.00
UROY cash_flow (annual, 2025-04-30) — Net PPE Purchase And Sale: -11584000.00
UROY cash_flow (quarterly, 2025-04-30) — Net PPE Purchase And Sale: 0.00
UROY cash_flow (annual, 2025-04-30) — Net Short Term Debt Issuance: 0.00
UROY cash_flow (quarterly, 2025-04-30) — Net Short Term Debt Issuance: 1282000.00
UROY balance_sheet (annual, 2025-04-30) — Net Tangible Assets: 294892000.00
UROY balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 294892000.00
UROY income_statement (annual, 2025-04-30) — Normalized EBITDA: -4305000.00
UROY income_statement (quarterly, 2025-04-30) — Normalized EBITDA: -859000.00
UROY income_statement (annual, 2025-04-30) — Normalized Income: -4918750.00
UROY income_statement (quarterly, 2025-04-30) — Normalized Income: -1001450.00
UROY cash_flow (annual, 2025-04-30) — Operating Cash Flow: -21630000.00
UROY cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: 3275000.00
UROY cash_flow (annual, 2025-04-30) — Operating Gains Losses: 865000.00
UROY cash_flow (quarterly, 2025-04-30) — Operating Gains Losses: 183000.00
UROY income_statement (annual, 2025-04-30) — Operating Income: -4806000.00
UROY income_statement (quarterly, 2025-04-30) — Operating Income: -980000.00
UROY income_statement (annual, 2025-04-30) — Operating Revenue: 15595000.00
UROY income_statement (quarterly, 2025-04-30) — Operating Revenue: 4688000.00
UROY balance_sheet (annual, 2025-04-30) — Ordinary Shares Number: 133636119.00
UROY balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 133636119.00
UROY balance_sheet (annual, 2025-04-30) — Other Equity Adjustments: 3714000.00
UROY balance_sheet (quarterly, 2025-04-30) — Other Equity Adjustments: 3714000.00
UROY income_statement (annual, 2025-04-30) — Other Gand A: 5919000.00
UROY income_statement (quarterly, 2025-04-30) — Other Gand A: 1098000.00
UROY income_statement (annual, 2025-04-30) — Other Income Expense: -641000.00
UROY income_statement (quarterly, 2025-04-30) — Other Income Expense: -183000.00
UROY cash_flow (annual, 2025-04-30) — Other Non Cash Items: -363000.00
UROY cash_flow (quarterly, 2025-04-30) — Other Non Cash Items: -72000.00
UROY income_statement (annual, 2025-04-30) — Other Non Operating Income Expenses: 224000.00
UROY income_statement (quarterly, 2025-04-30) — Other Non Operating Income Expenses: 0.00
UROY income_statement (annual, 2025-04-30) — Other Operating Expenses: 498000.00
UROY income_statement (quarterly, 2025-04-30) — Other Operating Expenses: 74000.00
UROY balance_sheet (annual, 2025-04-30) — Other Properties: 189000.00
UROY balance_sheet (quarterly, 2025-04-30) — Other Properties: 189000.00
UROY balance_sheet (annual, 2025-04-30) — Other Receivables: 426000.00
UROY balance_sheet (quarterly, 2025-04-30) — Other Receivables: 426000.00
UROY balance_sheet (annual, 2025-04-30) — Other Short Term Investments: 7147000.00
UROY balance_sheet (quarterly, 2025-04-30) — Other Short Term Investments: 7147000.00
UROY balance_sheet (annual, 2025-04-30) — Payables: 968000.00
UROY balance_sheet (quarterly, 2025-04-30) — Payables: 968000.00
UROY balance_sheet (annual, 2025-04-30) — Payables And Accrued Expenses: 968000.00
UROY balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 968000.00
UROY income_statement (annual, 2025-04-30) — Pretax Income: -5308000.00
UROY income_statement (quarterly, 2025-04-30) — Pretax Income: -1091000.00
UROY cash_flow (annual, 2025-04-30) — Proceeds From Stock Option Exercised: 26172000.00
UROY cash_flow (quarterly, 2025-04-30) — Proceeds From Stock Option Exercised: 126000.00
UROY cash_flow (annual, 2025-04-30) — Purchase Of Investment: -350000.00
UROY cash_flow (quarterly, 2025-04-30) — Purchase Of Investment: 0.00
UROY cash_flow (annual, 2025-04-30) — Purchase Of PPE: -11584000.00
UROY cash_flow (quarterly, 2025-04-30) — Purchase Of PPE: 0.00
UROY balance_sheet (annual, 2025-04-30) — Receivables: 468000.00
UROY balance_sheet (quarterly, 2025-04-30) — Receivables: 468000.00
UROY income_statement (annual, 2025-04-30) — Reconciled Cost Of Revenue: 12058000.00
UROY income_statement (quarterly, 2025-04-30) — Reconciled Cost Of Revenue: 4026000.00
UROY income_statement (annual, 2025-04-30) — Reconciled Depreciation: 120000.00
UROY income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 45000.00
UROY cash_flow (annual, 2025-04-30) — Repayment Of Debt: -65000.00
UROY cash_flow (quarterly, 2025-04-30) — Repayment Of Debt: 19284000.00
UROY balance_sheet (annual, 2025-04-30) — Restricted Cash: 110000.00
UROY balance_sheet (quarterly, 2025-04-30) — Restricted Cash: 110000.00
UROY balance_sheet (annual, 2025-04-30) — Retained Earnings: 17226000.00
UROY balance_sheet (quarterly, 2025-04-30) — Retained Earnings: 17226000.00
UROY income_statement (annual, 2025-04-30) — Salaries And Wages: 1926000.00
UROY income_statement (quarterly, 2025-04-30) — Salaries And Wages: 470000.00
UROY cash_flow (annual, 2025-04-30) — Sale Of Investment: 0.00
UROY cash_flow (quarterly, 2025-04-30) — Sale Of Investment: 0.00
UROY income_statement (annual, 2025-04-30) — Selling General And Administration: 7845000.00
UROY income_statement (quarterly, 2025-04-30) — Selling General And Administration: 1568000.00
UROY balance_sheet (annual, 2025-04-30) — Share Issued: 133636119.00
UROY balance_sheet (quarterly, 2025-04-30) — Share Issued: 133636119.00
UROY cash_flow (annual, 2025-04-30) — Short Term Debt Payments: 0.00
UROY cash_flow (quarterly, 2025-04-30) — Short Term Debt Payments: 19301000.00
UROY cash_flow (annual, 2025-04-30) — Stock Based Compensation: 784000.00
UROY cash_flow (quarterly, 2025-04-30) — Stock Based Compensation: 186000.00
UROY balance_sheet (annual, 2025-04-30) — Stockholders Equity: 294892000.00
UROY balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 294892000.00
UROY balance_sheet (annual, 2025-04-30) — Tangible Book Value: 294892000.00
UROY balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 294892000.00
UROY income_statement (annual, 2025-04-30) — Tax Effect Of Unusual Items: -129750.00
UROY income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: -27450.00
UROY income_statement (annual, 2025-04-30) — Tax Provision: 346000.00
UROY income_statement (quarterly, 2025-04-30) — Tax Provision: 66000.00
UROY income_statement (annual, 2025-04-30) — Tax Rate For Calcs: 0.15
UROY income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.15
UROY balance_sheet (annual, 2025-04-30) — Total Assets: 296069000.00
UROY balance_sheet (quarterly, 2025-04-30) — Total Assets: 296069000.00
UROY balance_sheet (annual, 2025-04-30) — Total Capitalization: 294892000.00
UROY balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 294892000.00
UROY balance_sheet (annual, 2025-04-30) — Total Debt: 209000.00
UROY balance_sheet (quarterly, 2025-04-30) — Total Debt: 209000.00
UROY balance_sheet (annual, 2025-04-30) — Total Equity Gross Minority Interest: 294892000.00
UROY balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 294892000.00
UROY income_statement (annual, 2025-04-30) — Total Expenses: 20401000.00
UROY income_statement (quarterly, 2025-04-30) — Total Expenses: 5668000.00
UROY balance_sheet (annual, 2025-04-30) — Total Liabilities Net Minority Interest: 1177000.00
UROY balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 1177000.00
UROY balance_sheet (annual, 2025-04-30) — Total Non Current Assets: 57908000.00
UROY balance_sheet (quarterly, 2025-04-30) — Total Non Current Assets: 57908000.00
UROY balance_sheet (annual, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 157000.00
UROY balance_sheet (quarterly, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 157000.00
UROY income_statement (annual, 2025-04-30) — Total Operating Income As Reported: -4806000.00
UROY income_statement (quarterly, 2025-04-30) — Total Operating Income As Reported: -980000.00
UROY income_statement (annual, 2025-04-30) — Total Other Finance Cost: 418000.00
UROY income_statement (quarterly, 2025-04-30) — Total Other Finance Cost: 0.00
UROY income_statement (annual, 2025-04-30) — Total Unusual Items: -865000.00
UROY income_statement (quarterly, 2025-04-30) — Total Unusual Items: -183000.00
UROY income_statement (annual, 2025-04-30) — Total Unusual Items Excluding Goodwill: -865000.00
UROY income_statement (quarterly, 2025-04-30) — Total Unusual Items Excluding Goodwill: -183000.00
UROY balance_sheet (annual, 2025-04-30) — Working Capital: 237141000.00
UROY balance_sheet (quarterly, 2025-04-30) — Working Capital: 237141000.00
UROY income_statement (quarterly, 2025-07-31) — +Operating Expense: 2237000.00
UROY income_statement (quarterly, 2025-07-31) — +Total Revenue: 33212000.00
UROY balance_sheet (quarterly, 2025-07-31) — Accounts Payable: 1130000.00
UROY balance_sheet (quarterly, 2025-07-31) — Accounts Receivable: 22000.00
UROY balance_sheet (quarterly, 2025-07-31) — Accumulated Depreciation: -1441000.00
UROY income_statement (quarterly, 2025-07-31) — Basic Average Shares: 133636271.00
UROY income_statement (quarterly, 2025-07-31) — Basic EPS: 0.01
UROY cash_flow (quarterly, 2025-07-31) — Beginning Cash Position: 12935000.00
UROY cash_flow (quarterly, 2025-07-31) — Capital Expenditure: -1044000.00
UROY balance_sheet (quarterly, 2025-07-31) — Capital Lease Obligations: 196000.00
UROY balance_sheet (quarterly, 2025-07-31) — Capital Stock: 273962000.00
UROY balance_sheet (quarterly, 2025-07-31) — Cash And Cash Equivalents: 8977000.00
UROY balance_sheet (quarterly, 2025-07-31) — Cash Cash Equivalents And Short Term Investments: 49085000.00
UROY balance_sheet (quarterly, 2025-07-31) — Cash Financial: 8977000.00
UROY cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Financing Activities: -11000.00
UROY cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Investing Activities: -35192000.00
UROY cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Operating Activities: 31217000.00
UROY cash_flow (quarterly, 2025-07-31) — Change In Account Payable: 162000.00
UROY cash_flow (quarterly, 2025-07-31) — Change In Inventory: 27866000.00
UROY cash_flow (quarterly, 2025-07-31) — Change In Payable: 162000.00
UROY cash_flow (quarterly, 2025-07-31) — Change In Payables And Accrued Expense: 162000.00
UROY cash_flow (quarterly, 2025-07-31) — Change In Prepaid Assets: -39000.00
UROY cash_flow (quarterly, 2025-07-31) — Change In Receivables: 20000.00
UROY cash_flow (quarterly, 2025-07-31) — Change In Working Capital: 28009000.00
UROY cash_flow (quarterly, 2025-07-31) — Changes In Account Receivables: 20000.00
UROY cash_flow (quarterly, 2025-07-31) — Changes In Cash: -3986000.00
UROY balance_sheet (quarterly, 2025-07-31) — Common Stock: 273962000.00
UROY balance_sheet (quarterly, 2025-07-31) — Common Stock Equity: 296982000.00
UROY income_statement (quarterly, 2025-07-31) — Cost Of Revenue: 27908000.00
UROY balance_sheet (quarterly, 2025-07-31) — Current Assets: 239451000.00
UROY balance_sheet (quarterly, 2025-07-31) — Current Capital Lease Obligation: 57000.00
UROY balance_sheet (quarterly, 2025-07-31) — Current Debt And Capital Lease Obligation: 57000.00
UROY balance_sheet (quarterly, 2025-07-31) — Current Liabilities: 1187000.00
UROY cash_flow (quarterly, 2025-07-31) — Depletion: 42000.00
UROY cash_flow (quarterly, 2025-07-31) — Depreciation: 14000.00
UROY cash_flow (quarterly, 2025-07-31) — Depreciation Amortization Depletion: 56000.00
UROY cash_flow (quarterly, 2025-07-31) — Depreciation And Amortization: 14000.00
UROY income_statement (quarterly, 2025-07-31) — Diluted Average Shares: 133673277.00
UROY income_statement (quarterly, 2025-07-31) — Diluted EPS: 0.01
UROY income_statement (quarterly, 2025-07-31) — Diluted NI Availto Com Stockholders: 1525000.00
UROY income_statement (quarterly, 2025-07-31) — EBIT: 1470000.00
UROY income_statement (quarterly, 2025-07-31) — EBITDA: 1526000.00
UROY cash_flow (quarterly, 2025-07-31) — Effect Of Exchange Rate Changes: 28000.00
UROY cash_flow (quarterly, 2025-07-31) — End Cash Position: 8977000.00
UROY cash_flow (quarterly, 2025-07-31) — Financing Cash Flow: -11000.00
UROY cash_flow (quarterly, 2025-07-31) — Free Cash Flow: 30173000.00
UROY cash_flow (quarterly, 2025-07-31) — Gain Loss On Investment Securities: 1716000.00
UROY income_statement (quarterly, 2025-07-31) — Gain On Sale Of Security: -1688000.00
UROY balance_sheet (quarterly, 2025-07-31) — Gains Losses Not Affecting Retained Earnings: 4269000.00
UROY income_statement (quarterly, 2025-07-31) — General And Administrative Expense: 2059000.00
UROY balance_sheet (quarterly, 2025-07-31) — Gross PPE: 60298000.00
UROY income_statement (quarterly, 2025-07-31) — Gross Profit: 5304000.00
UROY income_statement (quarterly, 2025-07-31) — Interest Expense: 4000.00
UROY income_statement (quarterly, 2025-07-31) — Interest Expense Non Operating: 4000.00
UROY income_statement (quarterly, 2025-07-31) — Interest Income: 91000.00
UROY income_statement (quarterly, 2025-07-31) — Interest Income Non Operating: 91000.00
UROY cash_flow (quarterly, 2025-07-31) — Interest Received Cfi: 90000.00
UROY balance_sheet (quarterly, 2025-07-31) — Inventory: 189767000.00
UROY balance_sheet (quarterly, 2025-07-31) — Invested Capital: 296982000.00
UROY cash_flow (quarterly, 2025-07-31) — Investing Cash Flow: -35192000.00
UROY balance_sheet (quarterly, 2025-07-31) — Long Term Capital Lease Obligation: 139000.00
UROY balance_sheet (quarterly, 2025-07-31) — Long Term Debt And Capital Lease Obligation: 139000.00
UROY cash_flow (quarterly, 2025-07-31) — Long Term Debt Payments: -17000.00
UROY cash_flow (quarterly, 2025-07-31) — Net Foreign Currency Exchange Gain Loss: -28000.00
UROY income_statement (quarterly, 2025-07-31) — Net Income: 1525000.00
UROY income_statement (quarterly, 2025-07-31) — Net Income Common Stockholders: 1525000.00
UROY income_statement (quarterly, 2025-07-31) — Net Income Continuous Operations: 1525000.00
UROY income_statement (quarterly, 2025-07-31) — Net Income From Continuing And Discontinued Operation: 1525000.00
UROY income_statement (quarterly, 2025-07-31) — Net Income From Continuing Operation Net Minority Interest: 1525000.00
UROY cash_flow (quarterly, 2025-07-31) — Net Income From Continuing Operations: 1466000.00
UROY income_statement (quarterly, 2025-07-31) — Net Income Including Noncontrolling Interests: 1525000.00
UROY income_statement (quarterly, 2025-07-31) — Net Interest Income: 87000.00
UROY cash_flow (quarterly, 2025-07-31) — Net Investment Purchase And Sale: -34238000.00
UROY cash_flow (quarterly, 2025-07-31) — Net Issuance Payments Of Debt: -17000.00
UROY cash_flow (quarterly, 2025-07-31) — Net Long Term Debt Issuance: -17000.00
UROY income_statement (quarterly, 2025-07-31) — Net Non Operating Interest Income Expense: 87000.00
UROY balance_sheet (quarterly, 2025-07-31) — Net PPE: 58857000.00
UROY cash_flow (quarterly, 2025-07-31) — Net PPE Purchase And Sale: -1044000.00
UROY balance_sheet (quarterly, 2025-07-31) — Net Tangible Assets: 296982000.00
UROY income_statement (quarterly, 2025-07-31) — Normalized EBITDA: 3214000.00
UROY income_statement (quarterly, 2025-07-31) — Normalized Income: 2959800.00
UROY cash_flow (quarterly, 2025-07-31) — Operating Cash Flow: 31217000.00
UROY cash_flow (quarterly, 2025-07-31) — Operating Gains Losses: 1688000.00
UROY income_statement (quarterly, 2025-07-31) — Operating Income: 3067000.00
UROY income_statement (quarterly, 2025-07-31) — Operating Revenue: 33212000.00
UROY balance_sheet (quarterly, 2025-07-31) — Ordinary Shares Number: 133638119.00
UROY balance_sheet (quarterly, 2025-07-31) — Other Equity Adjustments: 4269000.00
UROY income_statement (quarterly, 2025-07-31) — Other Gand A: 1641000.00
UROY income_statement (quarterly, 2025-07-31) — Other Income Expense: -1688000.00
UROY cash_flow (quarterly, 2025-07-31) — Other Non Cash Items: -87000.00
UROY income_statement (quarterly, 2025-07-31) — Other Operating Expenses: 178000.00
UROY balance_sheet (quarterly, 2025-07-31) — Other Properties: 175000.00
UROY balance_sheet (quarterly, 2025-07-31) — Other Receivables: 467000.00
UROY balance_sheet (quarterly, 2025-07-31) — Other Short Term Investments: 40108000.00
UROY balance_sheet (quarterly, 2025-07-31) — Payables: 1130000.00
UROY balance_sheet (quarterly, 2025-07-31) — Payables And Accrued Expenses: 1130000.00
UROY income_statement (quarterly, 2025-07-31) — Pretax Income: 1466000.00
UROY cash_flow (quarterly, 2025-07-31) — Proceeds From Stock Option Exercised: 6000.00
UROY cash_flow (quarterly, 2025-07-31) — Purchase Of Investment: -34238000.00
UROY cash_flow (quarterly, 2025-07-31) — Purchase Of PPE: -1044000.00
UROY balance_sheet (quarterly, 2025-07-31) — Receivables: 489000.00
UROY income_statement (quarterly, 2025-07-31) — Reconciled Cost Of Revenue: 27908000.00
UROY income_statement (quarterly, 2025-07-31) — Reconciled Depreciation: 56000.00
UROY cash_flow (quarterly, 2025-07-31) — Repayment Of Debt: -17000.00
UROY balance_sheet (quarterly, 2025-07-31) — Restricted Cash: 110000.00
UROY balance_sheet (quarterly, 2025-07-31) — Retained Earnings: 18751000.00
UROY income_statement (quarterly, 2025-07-31) — Salaries And Wages: 418000.00
UROY income_statement (quarterly, 2025-07-31) — Selling General And Administration: 2059000.00
UROY balance_sheet (quarterly, 2025-07-31) — Share Issued: 133638119.00
UROY cash_flow (quarterly, 2025-07-31) — Stock Based Compensation: 85000.00
UROY balance_sheet (quarterly, 2025-07-31) — Stockholders Equity: 296982000.00
UROY balance_sheet (quarterly, 2025-07-31) — Tangible Book Value: 296982000.00
UROY income_statement (quarterly, 2025-07-31) — Tax Effect Of Unusual Items: -253200.00
UROY income_statement (quarterly, 2025-07-31) — Tax Provision: -59000.00
UROY income_statement (quarterly, 2025-07-31) — Tax Rate For Calcs: 0.15
UROY balance_sheet (quarterly, 2025-07-31) — Total Assets: 298308000.00
UROY balance_sheet (quarterly, 2025-07-31) — Total Capitalization: 296982000.00
UROY balance_sheet (quarterly, 2025-07-31) — Total Debt: 196000.00
UROY balance_sheet (quarterly, 2025-07-31) — Total Equity Gross Minority Interest: 296982000.00
UROY income_statement (quarterly, 2025-07-31) — Total Expenses: 30145000.00
UROY balance_sheet (quarterly, 2025-07-31) — Total Liabilities Net Minority Interest: 1326000.00
UROY balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 58857000.00
UROY balance_sheet (quarterly, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 139000.00
UROY income_statement (quarterly, 2025-07-31) — Total Operating Income As Reported: 3067000.00
UROY income_statement (quarterly, 2025-07-31) — Total Unusual Items: -1688000.00
UROY income_statement (quarterly, 2025-07-31) — Total Unusual Items Excluding Goodwill: -1688000.00
UROY balance_sheet (quarterly, 2025-07-31) — Working Capital: 238264000.00
UROY income_statement (quarterly, 2025-10-31) — +Operating Expense: 3236000.00
UROY income_statement (quarterly, 2025-10-31) — +Total Revenue: 41000.00
UROY balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 968000.00
UROY balance_sheet (quarterly, 2025-10-31) — Accounts Receivable: 63000.00
UROY balance_sheet (quarterly, 2025-10-31) — Accumulated Depreciation: -1603000.00
UROY income_statement (quarterly, 2025-10-31) — Basic Average Shares: 134541984.00
UROY income_statement (quarterly, 2025-10-31) — Basic EPS: 0.02
UROY cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 8977000.00
UROY balance_sheet (quarterly, 2025-10-31) — Capital Lease Obligations: 183000.00
UROY balance_sheet (quarterly, 2025-10-31) — Capital Stock: 303059000.00
UROY balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 72533000.00
UROY balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 82326000.00
UROY balance_sheet (quarterly, 2025-10-31) — Cash Financial: 72533000.00
UROY cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: 28775000.00
UROY cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: 36879000.00
UROY cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: -2727000.00
UROY cash_flow (quarterly, 2025-10-31) — Change In Account Payable: -162000.00
UROY cash_flow (quarterly, 2025-10-31) — Change In Inventory: 0.00
UROY cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: -162000.00
UROY cash_flow (quarterly, 2025-10-31) — Change In Prepaid Assets: 213000.00
UROY cash_flow (quarterly, 2025-10-31) — Change In Receivables: -41000.00
UROY cash_flow (quarterly, 2025-10-31) — Change In Working Capital: 10000.00
UROY cash_flow (quarterly, 2025-10-31) — Changes In Account Receivables: -41000.00
UROY cash_flow (quarterly, 2025-10-31) — Changes In Cash: 62927000.00
UROY balance_sheet (quarterly, 2025-10-31) — Common Stock: 303059000.00
UROY balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 330427000.00
UROY income_statement (quarterly, 2025-10-31) — Cost Of Revenue: 29000.00
UROY balance_sheet (quarterly, 2025-10-31) — Current Assets: 272652000.00
UROY balance_sheet (quarterly, 2025-10-31) — Current Capital Lease Obligation: 58000.00
UROY balance_sheet (quarterly, 2025-10-31) — Current Debt And Capital Lease Obligation: 58000.00
UROY balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 1026000.00
UROY cash_flow (quarterly, 2025-10-31) — Depletion: 30000.00
UROY cash_flow (quarterly, 2025-10-31) — Depreciation: 14000.00